0001144204-17-028107.txt : 20170517
0001144204-17-028107.hdr.sgml : 20170517
20170517115301
ACCESSION NUMBER: 0001144204-17-028107
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170517
DATE AS OF CHANGE: 20170517
EFFECTIVENESS DATE: 20170517
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NORTHWEST BIOTHERAPEUTICS INC
CENTRAL INDEX KEY: 0001072379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943306718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-286907
FILM NUMBER: 17850664
BUSINESS ADDRESS:
STREET 1: 4800 MONTGOMERY LANE
STREET 2: SUITE 800
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (240) 497-9024
MAIL ADDRESS:
STREET 1: 4800 MONTGOMERY LANE
STREET 2: SUITE 800
CITY: BETHESDA
STATE: MD
ZIP: 20814
D
1
primary_doc.xml
X0707
D
LIVE
0001072379
NORTHWEST BIOTHERAPEUTICS INC
4800 MONTGOMERY LANE, SUITE 800
BETHESDA
MD
MARYLAND
20814
(240) 497-9024
DELAWARE
None
None
Corporation
true
Linda
F
Powers
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Executive Officer
Director
Alton
L
Boynton
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Executive Officer
Director
Robert
A
Farmer
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Director
Leslie
Goldman
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Executive Officer
Navid
Malik
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Director
Jerry
Jasinowski
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Director
J
Cofer
Black
4800 MONTGOMERY LANE, SUITE 800
Bethesda
MD
MARYLAND
20814
Director
Biotechnology
Decline to Disclose
- 06b
false
2017-05-02
false
true
true
true
false
0
Indefinite
52000
Indefinite
false
1
0
0
0
The company expects to offer an indeterminate amount of securities under the offering and does not at this time know the amount of gross proceeds that will be obtained.
false
NORTHWEST BIOTHERAPEUTICS INC
/s/ Linda F. Powers
Linda F. Powers
Chief Executive Officer
2017-05-17